|
Dear Dr. Jonathan A Eisen,
|
|
Greetings!
The purpose of this letter is to invite you to be as a Speaker for the upcoming 6th International Conference & Expo on Proteomics during March 29–31, 2016 Atlanta, USA. |
|
The aim to deliver a global platform to share knowledge and expertise with the scientific community on the advancements in the field of Proteomics. The conference anticipates leading worldwide researchers, scientists, academic scientists, industry researchers, scholars, decision makers and other professionals from across the globe. |
|
The theme of the conference is Revealing The Novel Innovation of Life Science, To Meet EmergingChallenges. |
|
Benefits: 1. Personal interaction with the Organizing Committee Members, Keynote speakers and other
eminent personalities for our future course of work. 2. Opportunity to conduct workshop/symposium with your team and colleagues based on your
research expertise. Some confirmed speakers for World Proteomics 2016:
Steven Pelech, President of Kinexus Bioinformatics Corp, Canada.
Krishna Dronamraju, President of Foundation for Genetic Research, USA.
Desmond Fitzgerald, Vice-President for Health Affairs, UCD, Ireland.
Laszlo Takacs, CEO of Biosystems International Kft, Hungary.
Cheorl-Ho Kim, Director, Sungkyunkwan University, Republic of Korea.
Sixue Chen, Director of Proteomics, University of Florida, USA.
Jochen Schwenk, KTH – Royal Institute of Technology, Sweden.
S.K. Jain, Head of Biochemistry, Hamdard University, India.
Raju Ravikumar, Professor, NIMHANS University, India.
Kian Kani, University of Southern California, USA
Ahmed Aldarmahi, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.
|
|
For more details please visit http://www.proteomicsconference.com/america/
|
|
In closing, we would be pleased and honored if you would consent to be speaker at the World Proteomics 2016 Conference. I look forward to receiving your reply
Please feel free to contact us for further details on the conference.
|
|
Respectfully, Mark Henry Jane
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
|
Tag: conference spam
Today in SPAMMY confereonce invitations
Dear Dr. Eisen,
On behalf of the Conference Chairs and Committees, it is my great pleasure to invite you to deliver an invited talk at the EMN Meeting on Membranes, which will be held in Novotel World Trade Centre Hotel, Dubai–United Arab Emirates, on April 05-08th, 2016.
Updated information about the EMN Meeting on Membranes can be found at http://emnmeeting.org/membranes/
The main purpose of EMN Membranes Meeting is to describe and discuss the newadvancement in Membranes Technology with its well-recognized and promising applications. We hope to bring together leading scientists, researchers, scholars and engineers from academia, R&D laboratories and industry around the world to exchange, share and learn the most interesting work done recently.
The workshops emphasis on promising aspects of Membrane usage are as follows: Bio absorbable Nano fiber Membranes, Membranes for Energy Conversion such as Fuel Cell, Gas Separation, Membrane Assembly and Translocation, Osmosis and Nano filtration Membranes, Membranes for Computing, Proton Exchange Membranes, Power Generation by Pressure Retarded Osmosis, Membranes for Environmental Protection and Membranes for Process Intensification and General in this broad field.
I do hope you can make time in your busy schedule to act as an invited speaker share your ideas on this topic. Your experience and comments will add an important dimension to what’s potentially a very important discussion for the field.
Please directly reply this email with your contact information, a tentative title of your invited presentation and which workshop is more appropriate for you or you can recommend other workshop for your talk if you could accept our invitation.
We are looking forward to hear from you and it will certainly be our pleasure and honor to see you in Dubai soon. Thanks!
Best Regards,
Mr. Muhammad Umar Farooq
My personal best SPAM conference invite yet …
Wow — just got an email invitation to one of those SPAMMY conferences. I quote the beginning below with the key part highlighted. There really is nothing else to say.
Dear Dr. Jonathan Eisen ,
On behalf of the organizing committee, we cordially invite you to propose a Speech as the Session Chair on your recent drug discovery project in the field of Benjamin Franklin Award Presentation for the Session 803: Database, Data Integration, Knowledge Management and Informatics Platform for Drug R & D of the Stream 8: Bio-IT and Data Management in Drug Discovery at the 12th Annual Congress of International Drug Discovery Science & Technology (IDDST-2014) with the theme “Shaping the Bright Future of Drug Discovery”, which will be held during November 21-23, 2014, Suzhou, China. Your prompt reply with a speech proposal will be highly appreciated! With your support, we hope to make this year event different from any others.
Sign of the apocalypse? Science conference SPAM hybridizes w/ Nigerian advanced fee SPAM.
Normally I do not share SPAM emails. But I have posted occasionally about Journal SPAM and Conference SPAM. So what do I do here. I just received an email that appears to be a hybrid between Conference SPAM and Nigerian advanced fee SPAM. OMG. The merging of two SPAM systems. Too bad the Conference is not about viagra – though since it is about Metagenomics perhaps it somehow got flagged due to studies of the penis or vagina microbiome? In this case I just had to post …
Dear Honored Sir or Madam,
I am Prof. Mohammed Kaoje Abubakar minister of Science for the Republic of Nigeria under former President Alhaji Umaru Musa Yar’Adua. In this role I became in control of large sums of money dedicated to scientific research and the exchange of ideas with researchers from across the globe. However, since the time of the unfortunate death of President Yar’Adua, I have been under intense scrutiny of the new director of the ministry and have been unable to complete my mission. Fortunately, I remain in charge of most of the 200 million dollars US, but the current government will only release the funds in conjunction with scientific activities involving prominent foreign national scientists like yourself.
Therefore, on behalf of the 3rd Nigerian Congress of Metagenomics I am pleased to welcome you to propose a speech on your recent discovery about the genomic basis for the origin and evolution of new functions at the congress by submitting your speech title and CV to us. Meanwhile, we hope you can share your stimulating data, valuable scientific information and influential experiences with other industrial leaders, professionals and research pioneers. You are encouraged to network and explore partnering opportunities.
As a branded Conference of Nigeria Congresses LLC, “Your Think Tank”, NCM continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.
l Keynote Forum – Presentations from Nobel Prize Laureate and Senior Leaders of Renowned Company
l Parallel Forum – 200+ Sessions and Symposiums provide 1000+ speech opportunities for experts from all of the world
l Welcome Banquet – All the participants enjoy the formal buffet dinner with wonderful performance show
l Project Matching Activity – Develop effective platform by free booths supply
l Keymakers Summit – Special Forum for Enterprisers to discuss hot issues face to face
l Exhibition and Poster Zone
The 3rd Nigerian Congress of Metagenomics is initiated for filling the gap between Eastern and West World for metagenomic professionals of free information exchange. In the past decade, NCM has attracted more than 5,000 enthusiastic speakers to communicate on the R & D advances in different therapeutic fields, which have generated great impact on the Chinese Bio/pharmaceutical development, enhanced Research and Development outsourcing, helped regional liaison of big pharma seeking partnership and searching talents, created a lot of opportunities for face-to-face network for multilateral collaboration by sharing both scientific and technological breakthroughs and speed up the process of many challenging drug discovery projects.
For more information PS: http:www.ncm.ng
Warri is a major oil city in Delta State, Nigeria, with a population of over 300,000 people. We look forward to seeing you in Warri for a stimulating and enjoyable conference. Kindest regards,
Prof. Mohammed Kaoje Abubakar8 for the organizing committee.
Elsevier: bringing us conference SPAM and also empty privacy policies (literally and figuratively)
Just got an announcement for a meeting from Elsevier that I have absolutely no potential connection too. It is yet another example of Science Conference Spam. Not really shocking to get it from Elsevier to be honest. But one part of the email struck me. This was the end of the message which I post below:
DATA PROTECTION NOTICE
This email has been sent to xxxxxxx from Elsevier B.V., Radarweg 29, 1043 NX Amsterdam, The Netherlands, using 22 Times B.V. technology and platform. This is a one-off email sent to you in the belief that it will be of interest. We will not add your name and email address to our database unless you request further information. If you wish to ensure that you will not receive a future marketing message from us about these products or services, please send a reply message to exclusionlist@elsevier.com. We respect your privacy and do not rent or sell your personal information to any non-affiliated third parties without your consent, except as may be stated in our privacy policy at: Elsevier privacy policy.
For the 22 Times privacy policy, please visit: 22 Times B.V. privacy policy.
We obtained your name and email address from ISI Thomson Scientific, 3501 Market street, Philadelphia, PA 19104 USA. If you wish to be removed from the ISI Thomson Scientific mailing lists, please click here ISI Thomson Scientific.
Copyright © 2012 Elsevier B.V. http://www.elsevier.com. registered office: Radarweg 29, 1043 NX Amsterdam, The Netherlands, under number 33156677, VAT number 002967455B65. All rights reserved.
This is a typical SPAMMY system where you get added to a list without requesting it. So – want to know what the “22 Times” privacy policy is? Well if you click the link you get
I can guess what it says but fortunately for those like me that don’t read Dutch, Google offers to translate. So I clicked on that offer just to be sure: “Page not found.” Great policy. Maybe I am supposed to pay to access it? I note – I have not posted the actual original link in the email because it has what appears to be some tracking information embedded in it. This I guess is what one could call an empty promise of privacy?
Anyway, next I clicked on the link for the Elsevier Privacy Policy. This time there is an actual policy there. Not surprisingly it is not very focused on the people at the other end. Here it is below, with some highlighting by me
Elsevier Website Privacy Policy
Elsevier is committed to maintaining your confidence and trust with respect to the privacy of the personally identifiable information we collect from you. This privacy policy sets forth our practices regarding collection, use and disclosure of information collected through or in connection with the Elsevier corporate website and all other Elsevier websites that post a link to this privacy policy (each a “Site”).
Collection and Registration of Personal Information
We may request users of this Site to provide personal information. The information collected directly from a user may include contact information such as the user’s name, e-mail address, and postal address.
In order to access certain content and to make use of the full functionality and advanced personalization features of the Site we ask you to register by completing and submitting a registration form, which may request additional information, such as work setting or principal professional field.
Automatic Collection of Information
This Site automatically collects certain information from your web browser regarding your use of the Site. Examples of information collected automatically from all users include the Internet Protocol (“IP”) address used to connect your computer to the Internet; computer and connection information such as browser type and version, operating system, and platform; and full Uniform Resource Locator (“URL”) click stream data, including date and time, and content you viewed or searched for on the Site.
This Site also collects information through the use of “cookies” or similar technologies. Cookies are anonymous, unique alphanumeric identifiers sent to your browser from a website’s computers and stored on your computer’s hard drive. The type of information collected as a result of a cookie being stored on your computer is specific to your computer. “Session” cookies collect information about your use of the Site (e.g., whether you are logged in) and to give you a more personalized browsing experience and help you navigate the Site more efficiently from page to page. These cookies are temporary and are deleted when you close your browser. “Persistent” cookies gather statistical information about repeat usage from your computer or workstation. In general, cookies do not contain personally identifiable information, but when you furnish your personal information through the Site, this information may be linked to the non-personally identifiable data stored in cookies sent to your browser from the Site.
We and our affiliated group companies and service providers may use cookies, “web beacons” or clear .gifs, or similar technologies to collect and use this information for the purposes of usage analysis (including for the purposes of reporting and paying royalties and license fees to third-party providers, such as authors, societies and other copyright holders and content distributors as well as tracking and analyzing user preferences and trends), delivery and management of our advertising, promotions and surveys, quality control and administering, customizing and improving the Site.
You can prevent your browser from accepting certain cookies, have the browser require your consent before a new cookie is placed in your browser, or block cookies altogether by accessing your browser’s privacy preferences menu. However, if you block cookies altogether, you may not be able to register, login to the Site, or make use of the full features and functionality of the Site.
How Personal Information Is Used
We use the personal information that you provide for such purposes as:
Completion and support of the activity for which the information was provided, such as allowing access to or delivery of our products or services, processing or fulfilling an order, or responding to your requests or inquiries;
Website and system administration, such as for the technical support of the Site and its computer system, including processing computer account information, information used in the course of securing and maintaining the Site, and verification of Site activity by the Site or its agents;
Tailoring or customizing content or design of the Site during a single visit to the Site and individualized personalization of the Site on repeat visits;
Research and development to enhance, evaluate and improve the Site and our products and services;
Pseudonymous analysis to create a profile used to determine the habits, interests or other characteristics of users for purposes of research, analysis and anonymous reporting; and
Communicating with you about changes or updates to the Site and our products and services and special offers, promotions or market research surveys.
We may on occasion also match or combine the personal information that you provide with information that we obtain from other sources or that is already in our records, whether collected online or offline or by predecessor or affiliated group companies, for such purposes.Disclosure of Personal Information to Third Parties
Access to your personal information is restricted to our employees, agents, representatives, service providers, and entities for which we are acting as an agent, licensee or publisher, such as societies, for the purposes set forth above. Your personal information may be used by all of our trading names and affiliated group companies and transferred to other countries for processing. These countries may not have similar data privacy laws, but if we transfer your information in this way, we will take steps to ensure that your information continues to be protected.
We also may share your personal information with our affiliated group companies worldwide and/or with non-affiliated third parties that wish to send you information about their products and services that may be of interest to you. We will not pass your personal information to such third parties if you indicate that you do not wish us to do so.
If this site offers an online content database or learning service (“Service”) and you access the Service through an institution-sponsored subscription, your personal information and certain usage data gathered through the Service, such as the number of items you downloaded, any non-subscribed items you accessed, and test scores, may be shared with your institution for the purposes of usage analysis, subscription management, course management, and testing and remediation. If your institution is a corporation or other business entity, additional usage data, such as the types of records you viewed and the number of searches you ran, also may be shared for the purposes of cost attribution and departmental budgeting.
We will not otherwise disclose any personal information without your consent except under the following circumstances:
in response to subpoenas, court orders, or legal process, or to establish or exercise our rights to defend against legal claims;
if we believe it is necessary to investigate, prevent, or take action regarding illegal activities, suspected fraud, safety of person or property, violation of our policies, or as otherwise required by law; and
if Elsevier, this Site, or a related asset or line of business is acquired by, transferred to or merged with another company.
Access and Changes to Your Registration Information and PreferencesRegistered users may access their identified contact information and other registration information and correct any discrepancies or update information upon log in at any time. The accuracy of such information is solely the responsibility of the user. No access is given to other data that may have been collected about users.
If you wish to receive alerts, newsletters, special offers or promotions from us, please indicate your preferences when you register or amend your preferences upon log in at any time. If you wish to cease receiving any of this information, amend your preferences either upon log in or by using the “opt-out” or unsubscribe option or other means provided within the communications you receive. We reserve the right to notify you of changes or updates to the Site whenever necessary.
Third-Party Advertisers
We may contract with third-party advertisers or their agents or service providers that post on the Site banner advertisements, which may link to other websites not under our control. or that use cookies, “web beacons” or clear .gifs, or similar technologies to collect and use user data to measure the effectiveness of their ads or deliver relevant marketing messages and advertisements. Use of these technologies by these third parties is subject to their own privacy policies, which may differ from this privacy policy. We are not responsible or liable for any content, advertising, products or other materials offered from such third parties.
Retention of Personal Information
We retain the personal information we collect from you for as long as the information is relevant to our business purposes or until you request that we remove the data.
Our Commitment to Data Security
We endeavor to keep your personal information confidential and protected against unauthorized access, loss, misuse or alteration through the use of appropriate administrative, physical and technical safeguards. The personal and demographic information about each user is stored on systems that are subject to appropriate physical and electronic security measures, and we limit employee access to and use of such information.
About This Privacy Policy
The foregoing is the current privacy policy of the Site. We reserve the right to change this policy at any time without notice. Any changes to this policy will be posted on this web page.
This Site may contain links to other websites that are beyond our control. Other websites to which you link may contain privacy policies that are different from this privacy policy. This privacy policy will not apply to data collected by or provided to other websites.
The websites of certain divisions or business units within the Elsevier group of companies may have privacy policies that are different from this privacy policy. In such cases, the privacy policy of that website will be posted and will supersede the terms of this policy in the event of a conflict.
Questions, Complaints, and Dispute Resolution
If you have any questions or comments regarding this privacy policy, please contact:
Elsevier Data Protection Officer
Elsevier Limited
The Boulevard
Langford Lane
Kidlington
Oxford OX5 1GB
United Kingdom
Email: DPO@elsevier.comIf at any time you believe that we have not adhered to this privacy policy or you have a complaint regarding the way your personal information is being handled, please contact the Elsevier Data Protection Officer. Disputes under this privacy policy will be resolved by the Elsevier Data Protection Officer, who will use commercially reasonable efforts to promptly investigate and, if necessary, to correct any problem.
Last revised: 28 May 2010
I don’t know about you but I am not feeling too comforted by this policy. For comparison here are some links to privacy policies of other science publishers:
- Privacy Policy : Nature.com
- Science/AAAS | Science Magazine: About the Journal: Privacy/Legal
- BioMed Central | Privacy
- Privacy Policy | PLoS
I leave it to others to judge these policies for themselves …
Hard to tell if this is a SPAM conference or not "4th Intntl. Science in Society Conference"
Hard to tell if this is email I just got is about a SPAM Conference or not.
Dear Colleague,
On behalf of the Conference Organizing Committee, I would like to inform you of the:
FOURTH INTERNATIONAL CONFERENCE ON SCIENCE IN SOCIETY
University of California, Berkeley, USA
17 – 19 November 2012
http://science-society.com/conference-2012/
This conference addresses the social impacts, values, pedagogies, politics and economics of science. It is an inclusive forum that welcomes a breadth of perspectives on science from practitioners, teachers and researchers representing a wide range of academic disciplines.
The Science in Society Conference is held annually in different locations around the world. The Inaugural Science in Society Conference was held at the University of Cambridge United Kingdom, in 2009. The Conference was held at the Universidad Carlos III de Madrid, Madrid, Spain in 2010; and the Catholic University of America, Washington DC, USA in 2011.
In addition to Plenary Presentations from leading speakers in the field, the Science in Society Conference includes parallel presentations by practitioners, teachers and researchers. We invite you to respond to the conference Call-for-Papers. Presenters submit their written papers for publication in the peer refereed “International Journal of Science in Society”. If you are unable to attend the conference in person, virtual registrations are also available which allow you to submit a paper for refereeing and possible publication in the journal as well as the option of uploading a video presentation to our YouTube channel.
The deadline for the next round in the call for papers (a title and short abstract) is 21 February 2012. Future deadlines will be announced on the conference website after this date. Proposals are reviewed within two weeks of submission. Full details of the conference, including an online proposal submission form, may be found at the conference website: http://science-society.com/conference-2012/ .
We look forward to receiving your proposal and hope you will be able to join us in Berkeley, USA in August.
YASSP (Yet another SPAMMY science publisher)
Just got an email from YAP (yet another publisher) recruiting articles for new journals. These ones seem just about as SPAMMY as some of the other recent ones to come out. Uggh. Double uggh. Email is posted below:
Introducing ‘Research Journal of Earth and Planetary Sciences”
Dear Colleague,
The Research Journal of Earth and Planetary Sciences (RJEPS) is a multidisciplinary peer-reviewed journal that will be published monthly by Global Research Journals (http://www.globalresearchjournals.org/?a=journal&id=rjeps). RJEPS is dedicated to increasing the depth of the subject across disciplines with the ultimate aim of expanding knowledge of the subject.
Editors and reviewers
RJEPS is seeking energetic, qualified and high profile researchers to join its editorial team as editors, subeditors or reviewers. Kindly send your resume to: rjeps.submit@globalresearchjournals.org
Call for Research Articles
RJEPS will cover all areas of the subject. The journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence, and will publish:
· Original articles in basic and applied research
· Case studies
· Critical reviews, surveys, opinions, commentaries and essays
We invite you to submit your manuscript(s) to: rjeps.submit@globalresearchjournals.org
for publication. Our objective is to inform authors of the decision on their manuscript(s) within four weeks of submission. Following acceptance, a paper will normally be published in the next issue. Guide to authors and other details are available on our website; http://www.globalresearchjournals.org/?a=journal&id=rjeps&menu=guidelines
RJEPS is an Open Access Journal
One key request of researchers across the world is unrestricted access to research publications. Open access gives a worldwide audience larger than that of any subscription-based journal and thus increases the visibility and impact of published works. It also enhances indexing, retrieval power and eliminates the need for permissions to reproduce and distribute content. RJEPS is fully committed to the Open Access Initiative and will provide free access to all articles as soon as they are published.
Best regards,
Otu Richard
Editorial Assistant
Research Journal of Earth and Planetary Sciences (RJEPS)
SPAM conference anyone
Just got this email. Could be a real conference but am sick of getting SPAM advertising it. I note – the emails look a lot like the ones I get from Bentham publishers. I wonder if they are working together or just use the same email service?
Dr.J.A.Eisen
Department of Evolution and Ecology
Department of Medical Microbiology and Immunology University of California Davis Genome Center University of California Davis Davis
CA
United States
Dear Dr.Eisen.,
It is our great pleasure to announce the “4th International Conference on Drug Discovery and Therapy” (4th ICDDT 2012) to be held in Dubai, UAE, from February 12th-15th, 2012, with Dr. Ferid Murad, Nobel Laureate and Prof. Atta-ur-Rahman, FRS as the conference Co-Presidents.
The 4th ICDDT is CME accredited by the Ministry of Health in which each medical specialist will earn up to maximum 18 hours of CME credits.
This event will represent an exciting series of conferences that have already attracted 22 Nobel Laureates to the previous three events. This four day event will feature recent findings from leading industrial, clinical and academic experts in the field, in the form of lectures and poters. Several Nobel Laureates including Prof. Jean-Marie Lehn (France), Prof. Michel Hurtmut (Germany), Prof. Robert Huber (Germany), Prof. Harald zur Hausen (Germany), Prof. Ferid Murad (USA), Prof. Mario Molina (USA) have already confirmed their participation in the 4th ICDDT along with several hundred top scientists and researchers from all over the world.
Abstracts for consideration as Invited or Session Lectures, and Poster Presentations can be submitted athttp://www.icddt4-01.com Alternatively, a maximum one-page length abstract written in English can be submitted to us by e-mail at info@icddt4-11.com All submitted abstracts received will be reviewed on the basis of scientific merit, novelty and practical application. Due to the limited slots available, only the best abstracts will be selected. The abstracts of the conference and a selection of the proceedings will be published in a high Impact Factor journal by an international publisher. We suggest that all interested participants to register and book their hotel in Dubai as early as possible.
Please join us in sunny Dubai for both work and enjoyment in February 2012 to explore a plethora of information on current research in drug discovery and therapy and to network with fellow academics and industrial researchers.
DEADLINE FOR ABSTRACT SUBMISSION TO PRESENT LECTURE / POSTER: JANUARY 15, 2012
For more details and to register, please visit the conference Web site at http://www.icddt4-01.com or alternatively you may contact info@icddt4-11.com
An associated exhibition will take place during the conference. Exhibitors and interested sponsors should contact the marketing department at info@icddt4-11.com To support this conference, you can download the conference poster from here http://www.icddt4-01.com/poster and post it on the public notice board.
We look forward to your participation at this important conference.
Sincerely yours,
Organizing Secretariat, ICDDT 2012
PO Box 7917
Saif Zone, Sharjah,
UAE
[Should you not want to receive any further emails, then please click here. Please also provide any other email address that you might be using to ensure that you do not receive any further emails]
More science conference spam
Got this invitation a minute ago:
Dear Dr.Jonathan Eisen,
I am Monica Fu from the organizing committee of the 4thAnnual World Congress of Vaccine. Cordially, we invite you to give an oral presentation at Session 418: Japanese Encephalitis, Junin, Hendra and Nipah Vaccines about your recent work. In order that you can learn the conference details and scientific program quickly, I am pleased to send you a conference brochure in the attachment. You are appreciated to reply me with a speech title to my email: monica@vaccinecon.com.
Certainly, if you have any questions about the conference, please do not hesitate to contact me.
Sincerely yours,
Ms. Monica Fu
Organizing Committee of WCV-2012
Only a minor complication. Never worked on anything related to this. Ahh – I love science conference spam.
Umm – thanks for the invitation but, umm – not going to go to this meeting
Wow. I get a lot of what one could call “Conference SPAM” with invitations to meetings that seem like nothing more than feedlots. But this one really takes the cake:
Dear Dr. Eisen JA.
It is with great pleasure that we invite you to attend the EPS Montreal International Gene Conference to be held November 3-4, 2011 in Montreal, Quebec, Canada. The conference will provide a forum for researchers in Genetics and Genomics to present cutting edge research and learn about the latest breakthroughs and technologies.
We would like to welcome you to our Conference as our valuable speaker and present your recent work and ideas of Environmental shotgun sequencing: its potential and challenges for studying the hidden world of microbes. that were published in PLoS Biol.. Please visit our website at http://www.epsglobal.ca and http://www.epswordlink.com for program details.
Montreal International Gene Conference is organized by EPS Global Medical development Inc. Professor Massaro, the editor-in-chief of the journal Cell Biochemistry and Biophysics (CBB) will be present at this event and call for submission of papers in this field. All of the papers presented in the conference may have a chance to be published in a special issue of Cell Biochemistry and Biophysics (CBB).
EPS Global Medical Development Inc. is a Canada-based biomedical consultant agency that promotes continuing academic education, knowledge transfer and scientific exchange through life sciences-oriented conferences. We are delighted to host the EPS Montreal International Gene Conference in Montreal in order to foster and promote excellence in Genetics and Genomics through education and research, and to provide leadership in promoting development of evidence-based clinical genetics and genomics as well as the basic research that supports these clinical advances.
We look forward to meeting you in Montreal and wish you all an enjoyable time.
Warmest regards,
Yao Lu, MD, PhDExecutive Chair of Montreal International Gene Conference 2011
President of EPS Global Medical Development Inc.
They are inviting me to present about a “recent” commentary paper I published in 2007. Umm – no thanks.
Jonathan Eisen's Lab 